TFR2 Antibodies

Santa Cruz Biotechnology features a diverse variety of TFR2 monoclonal antibodies for investigating transferrin receptor 2 (TFR2) in various biological processes. TFR2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Transferrin receptor 2 is a key player in iron homeostasis and is involved in the regulation of cellular iron uptake. TFR2 plays a crucial role in the pathophysiology of hereditary hemochromatosis, a genetic disorder that leads to excessive iron accumulation in the body. Understanding TFR2 function is essential for developing therapeutic strategies for iron-related disorders and for advancing knowledge of iron metabolism. Research utilizing TFR2 monoclonal antibodies has revealed significant insights into iron transport mechanisms and cellular regulation. Ongoing studies continue to uncover new aspects of TFR2's role in maintaining proper iron balance. Current investigations focus on how TFR2 dysfunction contributes to various pathological conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of iron metabolism and related diseases.